The bioflavonoid galangin blocks aryl hydrocarbon receptor activation and polycyclic aromatic hydrocarbon-induced pre-B cell apoptosis.

Bioflavonoids are plant compounds touted for their potential to treat or prevent several diseases including cancers induced by common environmental chemicals. Much of the biologic activity of one such class of pollutants, polycyclic aromatic hydrocarbons (PAH), is mediated by the aryl hydrocarbon receptor/transcription factor (AhR). For example, the AhR regulates PAH immunotoxicity that manifests as pre-B cell apoptosis in models of B cell development. Because bioflavonoids block PAH-induced cell transformation and are structurally similar to AhR ligands, it was postulated that some of them would suppress PAH-induced, AhR-dependent immunotoxicity, possibly through a direct AhR blockade. This hypothesis was tested using a model of B cell development in which pre-B cells are cultured with and are dependent on bone marrow stromal or hepatic parenchymal cell monolayers. Of seven bioflavonoids screened, galangin (3,5,7-trihydroxyflavone) blocked PAH-induced but not C(2)-ceramide- or H(2)O(2)-induced pre-B cell apoptosis. Because galangin blocked AhR-dependent reporter gene expression, AhR complex-DNA binding, and AhR nuclear translocation, inhibition of a relatively early step in AhR signaling was implicated. This hypothesis was supported by the ability of galangin to bind the AhR and stabilize AhR-90-kDa heat shock protein complexes in the presence of AhR agonists. These studies demonstrate the utility of pre-B cell culture systems in identifying compounds capable of blocking PAH immunotoxicity, define at least one mechanism of galangin activity (i.e., repression of AhR activation), and motivate the use of this and similar dietary bioflavonoids as relatively nontoxic inhibitors of AhR agonist activity and as pharmacologic agents with which to dissect AhR signaling pathways.

[1]  H. Ciolino,et al.  Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. , 1999, The Biochemical journal.

[2]  J. Giesy,et al.  Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. , 1996, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[3]  A. Fornace,et al.  Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm. , 1990, Environmental health perspectives.

[4]  S. Safe,et al.  Indole-3-carbinol and diindolylmethane as aryl hydrocarbon (Ah) receptor agonists and antagonists in T47D human breast cancer cells. , 1996, Biochemical pharmacology.

[5]  J. Reiners,et al.  Aryl Hydrocarbon Receptor Regulation of Ceramide-induced Apoptosis in Murine Hepatoma 1c1c7 Cells , 1999, The Journal of Biological Chemistry.

[6]  J. A. Blank,et al.  alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression. , 1987, Molecular pharmacology.

[7]  K. Medina,et al.  Stromal Cell Lines which Support Lymphocyte Growth , 1991 .

[8]  C. Riccardi,et al.  Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. , 1999, Blood.

[9]  O. Witte,et al.  Murine B cell lymphopoiesis in long term culture. , 1984, Journal of immunological methods.

[10]  N P Wray,et al.  Positive correlation between high aryl hydrocarbon hydroxylase activity and primary lung cancer as analyzed in cryopreserved lymphocytes. , 1982, Cancer research.

[11]  D. Sherr,et al.  Regulation of preB cell apoptosis by aryl hydrocarbon receptor/transcription factor-expressing stromal/adherent cells. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[12]  N Guthrie,et al.  Inhibition of human breast cancer cell proliferation and delay of mammary tumorigenesis by flavonoids and citrus juices. , 1996, Nutrition and cancer.

[13]  S. Safe,et al.  Cellular and molecular biology of aryl hydrocarbon (Ah) receptor-mediated gene expression. , 1995, Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement.

[14]  J. Reiners,et al.  Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. , 1999, Carcinogenesis.

[15]  S. Safe,et al.  Substituted flavones as aryl hydrocarbon (Ah) receptor agonists and antagonists. , 1996, Biochemical pharmacology.

[16]  S. Dertinger,et al.  Flavone antagonists bind competitively with 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) to the aryl hydrocarbon receptor but inhibit nuclear uptake and transformation. , 1999, Molecular pharmacology.

[17]  C. Bradfield,et al.  Ligand-dependent Interaction of the Aryl Hydrocarbon Receptor with a Novel Immunophilin Homolog in Vivo* , 1997, The Journal of Biological Chemistry.

[18]  P. Toselli,et al.  Induction of PreB cell apoptosis by 7,12-dimethylbenz[a]anthracene in long-term primary murine bone marrow cultures. , 1997, Toxicology and applied pharmacology.

[19]  F. Gonzalez,et al.  Bone marrow stromal cell cytochrome P4501B1 is required for pre-B cell apoptosis induced by 7,12-dimethylbenz[a]anthracene. , 1999, Molecular pharmacology.

[20]  Y. Hannun,et al.  Programmed cell death induced by ceramide. , 1993, Science.

[21]  G. Perdew,et al.  Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. , 1999, The Journal of biological chemistry.

[22]  J. Whitlock,et al.  Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Ueffing,et al.  Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. , 1999, Oncogene.

[24]  F. Gonzalez,et al.  Bone Marrow Stromal Cell Cytochrome P 4501 B 1 Is Required for Pre-B Cell Apoptosis Induced by 7 , 12-Dimethylbenz [ a ] anthracene 1 , 1999 .

[25]  D. Nebert,et al.  Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. , 2000, Biochemical pharmacology.

[26]  M. Ueffing,et al.  Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-κB , 1999, Oncogene.

[27]  H. Ciolino,et al.  Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. , 1998, Cancer research.

[28]  N. Kerkvliet,et al.  The role of polycyclic aromatic hydrocarbon metabolism in dimethylbenz[a]anthracene-induced pre-B lymphocyte apoptosis. , 1999, Toxicology and applied pharmacology.

[29]  H. Ciolino,et al.  The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor , 1999, British Journal of Cancer.

[30]  E. Skrzypczak‐Jankun,et al.  Why drinking green tea could prevent cancer , 1997, Nature.

[31]  R. Pollenz,et al.  The aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator protein show distinct subcellular localizations in Hepa 1c1c7 cells by immunofluorescence microscopy. , 1994, Molecular pharmacology.

[32]  C. Bradfield,et al.  Ah receptor signaling pathways. , 1996, Annual review of cell and developmental biology.

[33]  D. T. Dudley,et al.  PD98059 is an equipotent antagonist of the aryl hydrocarbon receptor and inhibitor of mitogen-activated protein kinase kinase. , 1998, Molecular pharmacology.

[34]  P. Toselli,et al.  Activation of the aryl hydrocarbon receptor/transcription factor and bone marrow stromal cell-dependent preB cell apoptosis. , 1997, Journal of immunology.

[35]  R. Agarwal,et al.  Skin cancer chemopreventive effects of a flavonoid antioxidant silymarin are mediated via impairment of receptor tyrosine kinase signaling and perturbation in cell cycle progression. , 1998, Biochemical and biophysical research communications.

[36]  O. Hankinson The aryl hydrocarbon receptor complex. , 1995, Annual review of pharmacology and toxicology.

[37]  S. Kuo,et al.  Dietary flavonoid and cancer prevention: evidence and potential mechanism. , 1997, Critical reviews in oncogenesis.

[38]  K. White,et al.  Suppression of the in vitro humoral immune response of mouse splenocytes by 7,12-dimethylbenz[a]anthracene metabolites and inhibition of immunosuppression by alpha-naphthoflavone. , 1991, Toxicology and applied pharmacology.

[39]  C. S. Yang,et al.  Effects of bioflavonoids on hepatic P450 activities. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.

[40]  T. Gasiewicz,et al.  Analysis of structural requirements for Ah receptor antagonist activity: ellipticines, flavones, and related compounds. , 1996, Biochemical pharmacology.

[41]  P. L. Rosalen,et al.  Antimicrobial Activity of Propolis on Oral Microorganisms , 1998, Current Microbiology.

[42]  W. Regelson,et al.  Review of the biology of Quercetin and related bioflavonoids. , 1995, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[43]  A. Folsom,et al.  Dietary flavonoid intake and risk of cardiovascular disease in postmenopausal women. , 1999, American journal of epidemiology.